- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
CRO industry faces consolidation
Sep 04, 2019
Astellas & FibroGen announced submission sNDA for Approval to Japan's Ministry of Health
Jan 30, 2020
Monoclonal Antibody Therapeutics (mABs) Market is expected to reach US$ 542.80 billion by 2030
Feb 05, 2024
Complementary and Alternative Medicine Market Players to See Huge Investments Opportunities by 2027 | Columbia Nutritional Inc.,Helio USA Inc.,Herb Pharm,Herbal Hills,Nordic Naturals & More
Apr 27, 2021
Alzheimer's Drugs Market is expected to reach US$ 22.01 billion by 2030
Feb 14, 2024
Purina Pro Plan Announces the First and Only Allergen-Reducing Cat Food
Feb 26, 2020
Allergan Foundation Giving Reaches $95 Million Since Inception
Dec 19, 2019